Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_assertion type Assertion NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_head.
- NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_assertion wasGeneratedBy ECO_0000203 NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_provenance.
- NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_assertion wasDerivedFrom befree-20140225 NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_provenance.
- NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_assertion SIO_000772 11255333 NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_provenance.
- NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_assertion evidence source_evidence_literature NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_provenance.
- NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_assertion description "[Results of RT-PCR for tyrosinase messenger RNA were positive in 18% (95% confidence interval [CI], 3%-22%) patients for stage I disease, 28% (95% CI, 23%-34%) for stage II disease, 19% (95% CI, 16%-21%) for stage I/II localized disease, 30% (95% CI, 26%-34%) for stage III disease, and 45% (95% CI, 41%-50%) for stage IV disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482174.RADX-7TpiAmen6f_hPdLmP5z5knnQWPIf-VKCohOXihZ0130_provenance.